D50E (p.Asp50Glu) variant of HTR2C (5-hydroxytryptamine receptor 2C)
D50E (p.Asp50Glu) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
D50E (p.Asp50Glu) variant details
- p.Asp50Glu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.04
- MetaSVM -1.00
- SIFT 0.55
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available